Observational studyScientific reports2025
U shaped association between fibrinogen and one year mortality in women undergoing coronary artery bypass grafting.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrinogen serves as a vital hemostatic factor and an early marker of inflammation, with established associations to unfavorable clinical outcomes, particularly in cardiovascular contexts. However, its specific effects in female populations are not well understood. This research aims to evaluate the relationship between serum fibrinogen concentrations and long-term mortality among female patients undergoing coronary artery bypass grafting (CABG). We analyzed data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The primary outcome assessed was one-year mortality, while secondary outcomes included hospital length of stay and incidence of sepsis. The associations between fibrinogen concentrations and clinical outcomes were evaluated retrospectively utilizing Cox proportional hazards models, along with subgroup analyses and restricted cubic splines (RCS). A total of 1,097 patients were included, with an average age of 70.8 years (range: 60.8–80.8) and a mean body mass index (BMI) of 31 kg/m² (range: 24–38). Analysis using Cox regression revealed a significantly elevated risk of one-year mortality linked to both low and high fibrinogen levels (Q1: Hazard ratio (HR) 2.91, 95%ConfidenceInterval (95% CI) 1.14 ~ 7.46; Q6: HR 4.3, 95% CI 1.66 ~ 11.13). Additionally, RCS analysis illustrated a U-shaped relationship between fibrinogen levels and mortality, identifying an inflection point at 174 mg/dL. These findings were corroborated by stratified and sensitivity analyses. In female patients undergoing CABG, both low and high fibrinogen levels are associated with an elevated risk of one year, mortality, exhibiting a U-shaped relationship. Further prospective research is warranted to validate the associations identified in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.